Molecular imaging identifies high-risk patients with heart disease

A study published in the August Journal of Nuclear Medicine (JNM) finds that molecular imaging -a non-invasive imaging procedure -can identify high-risk patients with potentially life-threatening cardiovascular conditions and help physicians determine which patients are best suited for implantable cardioverter defibrillator (ICD) therapy.

Read the whole article on Physorg

More from Physorg